• Total pharmaceutical expenditure as % of total health expenditure (Line chart)
  • Total pharmaceutical expenditure as % of total health expenditure (Bar chart)
  • Total pharmaceutical expenditure as % of total health expenditure (Boxplot chart)
Data set notes
European Health for All database

Indicators: 611
Updated: 15 June 2018
Downloads: 23251

The following abbreviations are used in the indicator titles:
•    SDR: age-standardized death rates (see HFA-DB user manual/Technical notes, page 13, for details)
•    FTE: full-time equivalent
•    PP: physical persons
•    PPP$: purchasing power parities expressed in US $, an internationally comparable scale reflecting the relative domestic purchasing powers of currencies.

Indicator notes
Total pharmaceutical expenditure as % of total health expenditure
Indicator code: E992708.T

The OECD definition is applied. It includes the consumption of pharmaceutical products supplied on prescriptions and obtained for self-medication (often referred to as over-the-counter products). Pharmaceuticals consumed in hospitals are excluded. The expenditure includes VAT and sales taxes, where applicable. The amount of consumption in hospitals is included under in-patient care.

The OECD Health Database is used as the primary data source for those countries that are OECD Member States._
Country notes
Albania
Health insurance institute.
Austria
Expenditure on pharmaceuticals includes expenditure on other medical non-durables (corresponds to
ICHA-HC.5.1).
Belgium
Source: National Institute for Health Insurance / calculations made by the Federal Public Service
Social Security since 2003. Pharmaceutical expenditure corresponds to the total of the provider
category Hc5 following the ?System of health accounts 2011? manual.
Bosnia and Herzegovina
National Health Account of B&H; http://www.who.int/nha/country/bih/en/ Ministry of Civil Affairs of
B&H, Health Insurance Fund of Federation of B&H; Health Insurance Fund of Republic of Srpska;
Department for Health of Brcko District
Cyprus
No data are available
Czechia
Source: Czech Statistical Office, Czech Health Accounts.
Denmark
Source: OECD health database (www.stats.oecd.org).
Estonia
Source: up to 1997 State Statistical Office. From 1998 National Institute for Health Development.
Corrections are in connection with the new definition, by which the pharmaceuticals consumed in
hospitals are excluded.
Estonia has provided total pharmaceutical expenditure as % of current health expenditure data for
year 2009-2014.
Finland
Source: Social Insurance Institute.
Georgia
Source: Ministry of Labour, Health and Social Affairs of Georgia (MOLHSA)
Germany
Source: Federal Statistical Office, Health Expenditure Accounts.
http://www.gbe-bund.de
Greece
For years 2009 to 2014 data are provided according to the system of Health Accounts (SHA 2011)
Methodology. GDP estimates refer to ESA 2010 Methodology
Iceland
Source: National Economic Institute.
Israel
Since 2000,is based on updated OECD definitions.
Source: National Accounts, Central Bureau of Statistics.
Italy
Source: Istat, National accounts. The OECD definition is applied.
Data for the period 1992-2012 have been estimated on the basis of the updated version of the
classification of economic activities (Ateco 2007, the national version of Nace Rev. 2) and of
products by activity (CPA 2008) and are consistent with the revised time series of national
accounts.
Latvia
Break in time series:
2013: Since 2013, SHA 2011 methodology used. As per Eurostat request, data for years 2011 (26.4%)
and 2012 (25.8%) were recalculated using SHA 2011 methodology.
Lithuania
Source: from 2004 onwards: Central Statistical Office. HC.5.1 data according to OECD SHA
methodology. Since 2013 methodology of SHA2011 is used.
Deviation from the definition: Since 2013 current expenditure on health care is used instead of
total health expenditure.
Malta
Source: National Statistics Office (data reviewed from 2001).
Montenegro
Data are not available.
Netherlands
Source of data: Statistics Netherlands: Cost and financing of health care. Pharmaceuticals consumed
in hospitals, mental hospitals, nursing homes etc. are not included in the pharmaceutical
expenditure here.
Portugal
Source of data: National Statistical Institute/OECD Coverage: National
Republic of Moldova
Starting from 2010 calculation of health financing indicators is based on the National Health
Accounts.
Romania
Source: National Institute of Statistics.
Serbia
Source of data: NHA data. The OECD definition has been applied. It includes consumption of
pharmaceutical products supplied on prescriptions and obtained for self-medication (often referred
to as over-the-counter products). Pharmaceuticals consumed in hospitals are excluded.
Slovenia
Source of data: Statistical Office of the Republic of Slovenia.
The former Yugoslav Republic of Macedonia
Source: Bulletin of Health Insurance Fund (HIF).
Ukraine
November 2002: Total expenditure on pharmaceuticals from state and local budgets as % of total
health expenditure from state and local budgets.
Source: Ministry of Health, the Economy and Finance Department.
United Kingdom
Coverage: Data refers to England only.
Deviation from the Definition: Data as at 31st December.